Haut.AI Unveils AI Clinical Software for the Future of Dermatology

In August 2026, Haut.AI unveiled its Clinical Studies Software, a validated platform designed to help skincare, beauty, ingredient, and dermatology companies conduct remote and hybrid clinical research across participant populations of hundreds to thousands. This platform applies standardized image capture and AI-based measurement and can reduce study setup time by more than 90%.

Standardize Skin Tests Anywhere With Haut.AI's New Model

The launch addresses a long-standing issue in clinical skin research, where assessments have relied on controlled environments, costly instruments, limited participant pools, and subjective grading by experts. Traditional studies typically involve 30 to 35 participants, limiting scale, increasing costs, and introducing variability in results due to differing expert opinions.

Haut.AI's AI model standardizes assessments across all images and conditions, providing consistent measurements that enable larger studies with hundreds or thousands of participants. This technology allows at-home images to match the quality of technician-captured photographs.

Anastasia Georgievskaya, CEO and Co-Founder of Haut.AI, also emphasized that the clinical research in beauty and skincare has reached an inflection point. Furthermore, the aim is to enhance clinical studies by enabling measurable skin data at scale so that research and development teams can measure continuously across larger populations with faster decisions.

Reliable Results: Why Haut.AI’s Precision Matters

Haut.AI's skin measurement technology highlights excellent repeatability (ICC 0.97–0.98) in a study with expert graders, correlating strongly with dermatology panels irrespective of how images were captured.  Varun Dwaraka also emphasized that Haut.AI's Clinical Studies Software provided standardized, image-derived measures of facial aging traits, allowing them to treat visible aging as a quantitative trait.

The New Standard in Remote Clinical Skin Measurement

Haut.ai's platform digitizes the clinical workflow through five integrated layers, reducing study setup from 8-16 weeks to just 2-3 days. Researchers can configure studies directly within the platform by managing participant lists, schedules, and capture settings. Participants then submit standardized images remotely and in clinic leveraging Haut.ai's LIQA™ technology. 

The software leverages AI to quantify 48 validated dermatological biomarkers and provides researchers with analytics, tracking, and efficacy measurements through a centralized dashboard. Results can be transformed into claims-ready reports for product development and consumer communication.

Haut.ai also automates repetitive study operations, which typically face steep expenses due to repeated tasks. With remote capture, operational costs are lowered by enabling larger cohorts at similar overall costs and delivering a 3x average return on investment across multiple studies per year.

Impact on the Healthcare Industry

This launch positively impacts the industry by lowering study setup time by over 90% and shifting hardware-bound clinical testing to scalable remote as well as hybrid models. It overcomes traditional limitations and evaluates face, body, and hair biomarkers, leveraging AI to automate and standardize dermatological and cosmetic efficacy research.

This technology transforms the clinical research industry by shifting trial timelines from months to days and enabling large-scale remote studies for 100 to 7,000-plus participants. It removes geographic limits through decentralized reach for cross-border testing without physical clinic visits. It also introduces continuous data integration by combining visible skin metrics with molecular and DNA datasets into precise quantitative information for multi-market trials and fast participant enrollment.

This addresses industry limitations by replacing human panel grading with universal AI standards to eliminate bias, fatigue, and inconsistent scoring. It also lowers logistical friction by enabling at-home photo captures through a simple link, with quality assurance and privacy and clinical roles through secure, anonymized data structures.

Impact of AI in Clinical Trials Industry

The global AI in clinical trials market is calculated at USD 2.60 billion in 2025 and is predicted to increase from USD 3.32 billion in 2026 to approximately USD 25.52 billion by 2035, expanding at a CAGR of 25.66% from 2026 to 2035.

According to Precedence Research, the launch impacts the industry by automating skin measurement for large remote and hybrid cohorts. It cuts study setup times, quantifies 48 standardized biomarkers, and replaces subjective visual grading with universal AI consistency.

This technology accelerates clinical trials by mitigating prep time by 90%, scaling cohorts to thousands, and enabling global, decentralized data collection while integrating with existing CRO workflows. It overcomes industry hurdles by mitigating human bias by ensuring high repeatability through AI, and securing privacy through patented and anonymized LIQA capture as well.

The platform replaces manual clinical grading, site monitoring, operational study management, and data reporting, streamlining processes without extra costs and allowing budget scalability with recruitment. It has been validated through large-scale studies by major global beauty and research and development leaders, helping extensive consumer research and formulation evaluations.

About Haut.AI

Haut.AI is an Estonia-based B2B SaaS company that leverages machine learning and user-submitted images to offer skin, hair, and body analysis. It helps global beauty brands replace subjective visual checks with data-backed intelligence, making scientific skincare claims measurable and accessible. The company offers tools like AI Skin and Body Analysis for health biomarkers, Skin. Chat for e-commerce shopping advice, SkinGPT for future skincare simulations, Skin Atlas for privacy-first photo anonymization, and Clinical Studies Software to lower dermatological trial setup times.